Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
DNA METHYLATION
Ustekinumab
Surgery
Bacteria
Gene methylation
Dysbiose
Upper gastrointestinal tract
Biomarker
Résistance
Inclusion
Immune cells
Clinical trial
Disease progression
Screening
HIV
DNA methylation
RISK
Alkylating agents
PCR
Tuberculosis
MALT
Colectomy
Patients experience
IL23
CARCINOGENESIS
Intestinal crypts
Colon
Crohn's disease
Colonic epithelial primary cells
Tailored therapy
Therapeutics
Stricture
18 FDG-PET/CT
Venous thromboembolism
Small molecules
Heart disease risk factors
Safety
Dysbiosis
Gene expression
Algorithm
Primary sclerosing cholangitis
Eradication
Parvimonas micra
Inflammatory Bowel Diseases
Colorectal cancer Colibactin and lipids
Disease Progression
Neoadjuvant chemotherapy
Thérapie ciblée
Anti-TNF
Crohn’s disease
Drug
Original Article Clinical
Contraindication
Clinical guidelines
Cost effectiveness
Rituximab
Microbiote
Immunosuppressant
IL12
Cell adhesion
Survival
Methylation
Méthylation
MICROBIOTA
Monitoring
Endoscopic treatment
Maintenance therapy
Resistance
Ulcerative colitis
Over 80s
Gènes
Disability
Colon cancer
Cancer
Fecal microbiota
COLON-CANCER
MARKER
Effectiveness
Eligibility
IBD
Consensus
Acceptability
Patient-reported outcome
T1118 translocation
Colorectal cancer
Bactéries
Anti-TNF agents
Genes
Inflammatory bowel disease
Vedolizumab
Epigenetics
Rituximab plus chlorambucil
Biologics
Inhibitor
Inflammatory bowel diseases
Epigénétiques
MORTALITY
Microbiota
Helicobacter pylori
Kidney diseases
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|